482 related articles for article (PubMed ID: 29325985)
1. Platelet-Activating Antibodies Are Detectable at the Earliest Onset of Heparin-Induced Thrombocytopenia, With Implications for the Operating Characteristics of the Serotonin-Release Assay.
Warkentin TE; Arnold DM; Kelton JG; Sheppard JI; Smith JW; Nazy I
Chest; 2018 Jun; 153(6):1396-1404. PubMed ID: 29325985
[TBL] [Abstract][Full Text] [Related]
2. A Novel PF4-Dependent Platelet Activation Assay Identifies Patients Likely to Have Heparin-Induced Thrombocytopenia/Thrombosis.
Padmanabhan A; Jones CG; Curtis BR; Bougie DW; Sullivan MJ; Peswani N; McFarland JG; Eastwood D; Wang D; Aster RH
Chest; 2016 Sep; 150(3):506-15. PubMed ID: 26905366
[TBL] [Abstract][Full Text] [Related]
3. Distinguishing between anti-platelet factor 4/heparin antibodies that can and cannot cause heparin-induced thrombocytopenia.
Nazi I; Arnold DM; Warkentin TE; Smith JW; Staibano P; Kelton JG
J Thromb Haemost; 2015 Oct; 13(10):1900-7. PubMed ID: 26291604
[TBL] [Abstract][Full Text] [Related]
4. Beneficial effect of exogenous platelet factor 4 for detecting pathogenic heparin-induced thrombocytopenia antibodies.
Vayne C; Guery EA; Kizlik-Masson C; Rollin J; Bauters A; Gruel Y; Pouplard C
Br J Haematol; 2017 Dec; 179(5):811-819. PubMed ID: 29048130
[TBL] [Abstract][Full Text] [Related]
5. Timeline of heparin-induced thrombocytopenia seroconversion in serial plasma samples tested using an automated latex immunoturbidimetric assay.
Warkentin TE; Sheppard JI; Smith JW; Arnold DM; Nazy I
Int J Lab Hematol; 2019 Aug; 41(4):493-502. PubMed ID: 31050876
[TBL] [Abstract][Full Text] [Related]
6. Serotonin-release assay-negative heparin-induced thrombocytopenia.
Warkentin TE; Nazy I; Sheppard JI; Smith JW; Kelton JG; Arnold DM
Am J Hematol; 2020 Jan; 95(1):38-47. PubMed ID: 31621093
[TBL] [Abstract][Full Text] [Related]
7. A diagnosis of heparin-induced thrombocytopenia with combined clinical and laboratory methods in cardiothoracic surgical intensive care unit patients.
Demma LJ; Winkler AM; Levy JH
Anesth Analg; 2011 Oct; 113(4):697-702. PubMed ID: 21788317
[TBL] [Abstract][Full Text] [Related]
8. HITlights: a career perspective on heparin-induced thrombocytopenia.
Warkentin TE
Am J Hematol; 2012 May; 87 Suppl 1():S92-9. PubMed ID: 22367928
[TBL] [Abstract][Full Text] [Related]
9. Laboratory diagnosis of heparin-induced thrombocytopenia.
Warkentin TE
Int J Lab Hematol; 2019 May; 41 Suppl 1():15-25. PubMed ID: 31069988
[TBL] [Abstract][Full Text] [Related]
10. Serotonin-release assay-positive but platelet factor 4-dependent enzyme-immunoassay negative: HIT or not HIT?
Warkentin TE; Smythe MA; Ali MA; Aslam N; Sheppard JI; Smith JW; Moore JC; Arnold DM; Nazy I
Am J Hematol; 2021 Mar; 96(3):320-329. PubMed ID: 33326124
[TBL] [Abstract][Full Text] [Related]
11. Early-onset and persisting thrombocytopenia in post-cardiac surgery patients is rarely due to heparin-induced thrombocytopenia, even when antibody tests are positive.
Selleng S; Malowsky B; Strobel U; Wessel A; Ittermann T; Wollert HG; Warkentin TE; Greinacher A
J Thromb Haemost; 2010 Jan; 8(1):30-6. PubMed ID: 19793190
[TBL] [Abstract][Full Text] [Related]
12. A Platelet Factor 4-Dependent Platelet Activation Assay Facilitates Early Detection of Pathogenic Heparin-Induced Thrombocytopenia Antibodies.
Jones CG; Pechauer SM; Curtis BR; Bougie DW; Irani MS; Dhakal B; Pierce B; Aster RH; Padmanabhan A
Chest; 2017 Oct; 152(4):e77-e80. PubMed ID: 28991552
[TBL] [Abstract][Full Text] [Related]
13. Improving clinical interpretation of the anti-platelet factor 4/heparin enzyme-linked immunosorbent assay for the diagnosis of heparin-induced thrombocytopenia through the use of receiver operating characteristic analysis, stratum-specific likelihood ratios, and Bayes theorem.
Raschke RA; Curry SC; Warkentin TE; Gerkin RD
Chest; 2013 Oct; 144(4):1269-1275. PubMed ID: 23703622
[TBL] [Abstract][Full Text] [Related]
14. Fibronectin modulates formation of PF4/heparin complexes and is a potential factor for reducing risk of developing HIT.
Krauel K; Preuße P; Warkentin TE; Trabhardt C; Brandt S; Jensch I; Mandelkow M; Hammer E; Hammerschmidt S; Greinacher A
Blood; 2019 Feb; 133(9):978-989. PubMed ID: 30573633
[TBL] [Abstract][Full Text] [Related]
15. Comparison of two PF4/heparin ELISA assays for the laboratory diagnosis of heparin-induced thrombocytopenia.
Izban KF; Lietz HW; Hoppensteadt DA; Jeske WP; Fareed J; Bakhos M; Walenga JM
Semin Thromb Hemost; 1999; 25 Suppl 1():51-6. PubMed ID: 10357152
[TBL] [Abstract][Full Text] [Related]
16. Dimeric FcγR ectodomains detect pathogenic anti-platelet factor 4-heparin antibodies in heparin-induced thromobocytopenia.
Wines BD; Tan CW; Duncan E; McRae S; Baker RI; Andrews RK; Esparon S; Gardiner EE; Hogarth PM
J Thromb Haemost; 2018 Dec; 16(12):2520-2525. PubMed ID: 30269432
[TBL] [Abstract][Full Text] [Related]
17. Prospective observational evaluation of the particle immunofiltration anti-platelet factor 4 rapid assay in MICU patients with thrombocytopenia.
Andrews DM; Cubillos GF; Paulino SK; Seckinger DL; Kett DH
Crit Care; 2013 Jul; 17(4):R143. PubMed ID: 23876263
[TBL] [Abstract][Full Text] [Related]
18. Heparin-platelet factor 4 antibodies in intensive care patients: an observational seroprevalence study.
Levine RL; Hergenroeder GW; Francis JL; Miller CC; Hursting MJ
J Thromb Thrombolysis; 2010 Aug; 30(2):142-8. PubMed ID: 19911252
[TBL] [Abstract][Full Text] [Related]
19. Physiological changes in membrane-expressed platelet factor 4: implications in heparin-induced thrombocytopenia.
Prechel MM; Jeske WP; Walenga JM
Thromb Res; 2010 Apr; 125(4):e143-8. PubMed ID: 19931120
[TBL] [Abstract][Full Text] [Related]
20. Prevalence, isotype, and functionality of antiheparin-platelet factor 4 antibodies in patients treated with heparin and clinically suspected for heparin-induced thrombocytopenia. The pathogenic role of IgG.
Untch B; Ahmad S; Jeske WP; Messmore HL; Hoppensteadt DA; Walenga JM; Lietz H; Fareed J
Thromb Res; 2002 Jan; 105(2):117-23. PubMed ID: 11958801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
